Clinical Trial Update: GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial studying vorinostat and lapatinib in advanced solid tumors and advanced breast cancer was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neoplasm Metastasis

Drugs mentioned

• Lapatinib (Lapatinib)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-04-24